Pneumococcal Vaccination in Immunocompromised Hosts: An Update
Claire Froneman, Peter Kelleher, Ricardo Jorge Paixão José
Abstract
Open-access reader
Claire Froneman, Peter Kelleher, Ricardo Jorge Paixão José
Abstract
Open-access reader
, are a common cause of morbidity and mortality worldwide. It particularly affects those at the extremes of age and immunocompromised individuals. Preventing pneumococcal disease is paramount in at risk individuals, and pneumococcal vaccination should be offered. Here, we discuss the role of pneumococcal vaccination in specific groups of immunocompromised hosts.
OpenAlex reports 15 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
, are a common cause of morbidity and mortality worldwide. It particularly affects those at the extremes of age and immunocompromised individuals. Preventing pneumococcal disease is paramount in at risk individuals, and pneumococcal vaccination should be offered. Here, we discuss the role of pneumococcal vaccination in specific groups of immunocompromised hosts.
Key concepts: Streptococcus pneumoniae, Vaccination, Pneumococcal disease, Pneumococcal infections, Pneumococcal vaccination, Immunology, Medicine, Pathogen